Zanbrutinib, Lenalidomide Plus R‐CHOP (ZR2‐CHOP) As the First‐line Treatment for Non‐gcb Diffuse Large B‐cell Lymphoma: an Updated Analysis of Efficacy and Tolerability
Hematological Oncology(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Hematological Oncology(2023)